TWO new low-cost point-of-care (POC) analysers, for diabetes management and ketosis testing, will be introduced at November’s Medica exhibition in Dusseldorf, Germany, by EKF Diagnostics.
The show will see the European launch of the Quo-Lab glycated haemoglobin (HbA1c) analyser for diabetes, which the company says provides highly accurate, affordable and easy-to-use technology for doctor’s surgeries, diabetes clinics, and laboratories. This semi-automated instrument delivers ‘lab-accurate’ results within four minutes, says EKF, requiring just 4ul of venous or finger prick blood.
HbA1c monitoring is growing in popularity for the detection and management of diabetes, and the Quo-Lab instrument is aimed at locations with limited economic resources where diabetes is an growing public health issue.
EKF will also unveil its first strip-based ketone analyser, the Stat-Site M bHB, which promises to take testing for ketoacidosis out of the laboratory and into the emergency room. Beta-Hydroxybutyrate (bHB) is the main ketone produced during ketosis and provides a quantitative and accurate assessment of patients displaying symptoms of ketosis.